Growing patient awareness and the search for more individualized digestive healthcare are expected to support the France irritable bowel syndrome treatment market over the coming years. The market is projected to grow from USD 89.15 million in 2024 to USD 96.43 million in 2025, reaching USD 211.5 million by 2035. This forecast represents a CAGR of 8.17% during 2025–2035. Increased...
